Find a clinical trial

Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.

Within
miles of
Two nurses discuss patient notes in a chemotherapy unit

A study about experiences of radiotherapy for gynaecological cancers

The research is looking into patients’ experiences of radiotherapy treatment for gynaecological cancers with the aim to: increase understanding of how radiotherapy impacts on social, personal and sexual lives and longer-term post-treatment experiences of gynaecological cancer explore the experiences of those who are/have been carers or sign…

A woman with ovarian cancer wearing a coat and green jumper walking down a hospital corridor

ARIEL 4: A study of rucaparib or chemotherapy in BRCA positive ovarian cancer

In this trial, the researchers are trying to find out whether it's safe and effective to use a PARP inhibitor rather than standard chemotherapy in women with a BRCA gene mutation who've had two previous chemotherapy treatments. The drugs involved in this trial: Rucaparib – a targeted treatment known as a PARP inhibitor Paclitaxel – a sta…

Close up of a woman looking at Target Ovarian Cancer's website on her phone during chemotherapy

CEBOC: A study into the safety of cediranib in the prevention of bowel perforation

The main purpose of conducting the trial is to: determine the safety of combining cediranib, a VEGF inhibitor, with paclitaxel a weekly chemotherapy regime find out how well the treatment works in terms of shrinking the cancer and preventing bowel obstruction. If the cancer responds to this treatment then after the course of paclitaxel…

An ovarian cancer researching looking into a microscope

Centurion: a trial looking at rucaparib with immunotherapy in relapsed ovarian cancer

The purpose of this trial is to find out how safe and effective it is to have either one or two immunotherapy drugs alongside the parp inhibitor Rucaparib. Researchers want to find out if using the different combination of drugs will prolong the time it takes for your cancer to come back compared with being treated with Rucaparib on its own. The…

Close up of a woman scrolling through Target Ovarian Cancer's website on her phone during chemotherapy

DICE: A trial of TAK228 and weekly paclitaxel chemotherapy in recurrent ovarian cancer

This study is looking at using a drug called TAK228 (new drug) in combination with paclitaxel (a standard chemotherapy drug) to see if it's a more effective way of treating ovarian cancer. The drugs involved in this trial are: TAK228 (new drug) – a drug that is thought to interfere with cell growth and may slow or stop cancer cells from di…

Three female researchers wearing lab coats looking at and pointing to information on a computer screen

EMBRACE: A study to collect information about inherited faulty cancer genes

This study collects information about people who have inherited faulty cancer genes. Inheriting a faulty gene means that a person is at a higher risk of developing certain cancers. A fault in the BRCA1 or BRCA2 genes means that a person is more likely to develop cancers of the breast, ovary or prostate. As well as the BRCA1 and BRCA2 genes, we n…